Dr Deborah Hursh, Senior Investigator, Cell and Tissue Therapy Branch, CBER at the Food and Drug Administration, presented at last year's Stem Cells USA & Regenerative Medicine Congress on the topic, â€˜Understanding the regulatory framework for stem cell-based products and regenerative medicine.'
In her presentation, Deobrah gives an overview on:
- Navigating the scientific challenges involved
- FDA approaches on biologics, devices, and combined regulation of the two
- Is there a possibility for international regulatory harmonization in this field?
For up to date information on the stem cells and regenerative medicine market, register now for Stem Cells USA & Regenerative Medicine Congress.